Ana de Lorenzo‐Pinto

PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

Juan Vicente-Valor, Xandra García‐González, Sara Ibáñez-García et al. · Biomedicine & Pharmacotherapy · 2021 · 25 citations · Full text

Cancellations of elective surgical procedures due to inadequate management of chronic medications

Ana de Lorenzo‐Pinto, C Ortega-Navarro, Almudena Ribed et al. · Journal of Clinical Pharmacy and Therapeutics · 2019 · 16 citations

Implementation of smart pump technology in a paediatric intensive care unit

Silvia Manrique‐Rodríguez, Amelia Sánchez-Galindo, Ana de Lorenzo‐Pinto et al. · Health Informatics Journal · 2014 · 13 citations

Pediatric Heart Disease, Clinical Specialties, Education +21

Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

Esther Chamorro‐de‐Vega, Álvaro Giménez‐Manzorro, Carmen Guadalupe Rodríguez-González et al. · Annals of Pharmacotherapy · 2016 · 11 citations

Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

Esther Chamorro‐de‐Vega, Carmen Guadalupe Rodríguez-González, Álvaro Giménez‐Manzorro et al. · International Journal of Clinical Practice · 2017 · 11 citations